Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yen Nguyen

Showing results (271-280 of 319) with videos related to

Pageof 32
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Discovery of a potent and selective c-Kit inhibitor for the treatment of inflammatory diseasesNing Chen, Roland W Bürli, Susana Neira, et al.
SSM. Qualitative Research in Health|June 24, 2024
Social cohesion among healthcare workers during COVID-19: Qualitative research in Indonesia, Nepal, and VietnamHa Nguyen Thanh, Ida Ayu Sutrisni, Samita Rijal, et al.
Hepatology (Baltimore, Md.)|March 4, 2017
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III StudyChristophe Hézode, Massimo Colombo, Marc Bourlière, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2006
Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant womenJashvant D Unadkat, Diane W Wara, Michael D Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2018
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD TrialChloe Orkin, Kathleen E Squires, Jean-Michel Molina, et al.
Biomarker Research|May 4, 2024
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradationBarbora Orlikova-Boyer, Anne Lorant, Sruthi Reddy Gajulapalli, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 13, 2026
Longitudinal multi-omics profiling of spinal muscular atrophyIvana Dabaj, Thi Hai Yen Nguyen, Emmanuelle Lagrue, et al.
Medicine|June 16, 2026
Prognostic performance of the mNUTRIC score for in-hospital mortality in critically Ill patients with severe and critical COVID-19: A retrospective cohort studyNhuan Thu To, Tuyet Phuong Bui, Van Hoang Nam Ho, et al.
Lancet (London, England)|October 13, 2015
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 studyDavid Roth, David R Nelson, Annette Bruchfeld, et al.
Parasites & Vectors|November 11, 2017
Incidence of dengue and chikungunya viruses in mosquitoes and human patients in border provinces of VietnamKim Lien Pham Thi, Laurence Briant, Laurent Gavotte, et al.
Pageof 32

Showing results (271-280 of 319) with videos related to

Sort By:
Pageof 32
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Discovery of a potent and selective c-Kit inhibitor for the treatment of inflammatory diseasesNing Chen, Roland W Bürli, Susana Neira, et al.
SSM. Qualitative Research in Health|June 24, 2024
Social cohesion among healthcare workers during COVID-19: Qualitative research in Indonesia, Nepal, and VietnamHa Nguyen Thanh, Ida Ayu Sutrisni, Samita Rijal, et al.
Hepatology (Baltimore, Md.)|March 4, 2017
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III StudyChristophe Hézode, Massimo Colombo, Marc Bourlière, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2006
Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant womenJashvant D Unadkat, Diane W Wara, Michael D Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2018
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD TrialChloe Orkin, Kathleen E Squires, Jean-Michel Molina, et al.
Biomarker Research|May 4, 2024
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradationBarbora Orlikova-Boyer, Anne Lorant, Sruthi Reddy Gajulapalli, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 13, 2026
Longitudinal multi-omics profiling of spinal muscular atrophyIvana Dabaj, Thi Hai Yen Nguyen, Emmanuelle Lagrue, et al.
Medicine|June 16, 2026
Prognostic performance of the mNUTRIC score for in-hospital mortality in critically Ill patients with severe and critical COVID-19: A retrospective cohort studyNhuan Thu To, Tuyet Phuong Bui, Van Hoang Nam Ho, et al.
Lancet (London, England)|October 13, 2015
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 studyDavid Roth, David R Nelson, Annette Bruchfeld, et al.
Parasites & Vectors|November 11, 2017
Incidence of dengue and chikungunya viruses in mosquitoes and human patients in border provinces of VietnamKim Lien Pham Thi, Laurence Briant, Laurent Gavotte, et al.
Pageof 32